Testing of pituitary hormones including a morning ACTH, luteinization hormone, FSH, estradiol (premenopausal females), testosterone (males), and prolactin is recommended when there an increased risk of hypophysitis, especially when CTLA-4 and PD-1 inhibitors are combined. The gene discussed is CTLA4; the disease is hypophysitis.